Song S Y, Chung J W, Han J K, Lim H G, Koh Y H, Park J H, Lee H S, Kim C Y
Department of Radiology and Institute of Radiation Medicine, Seoul National University College of Medicine, and Clinical Research Institute, Seoul National University Hospital, Korea.
J Vasc Interv Radiol. 2001 Mar;12(3):313-20. doi: 10.1016/s1051-0443(07)61910-1.
To evaluate the incidence of, predisposing factors for, and clinical outcome of liver abscess developing in patients with hepatic tumors after transcatheter oily chemoembolization (TOCE).
During the past 6-year period, 2,439 patients with hepatic tumors underwent a total of 6,255 TOCE procedures. With a retrospective review of medical records, the authors evaluated the occurrence of liver abscess, the statistical significance of potential predisposing factors including portal vein obstruction, metastatic tumors, biliary abnormalities (type 1, simple biliary obstruction; type 2, status prone to ascending biliary infection), malignant gastrointestinal mucosal lesions, and additional gelatin sponge particle embolization in liver abscess formation, and the clinical outcome of abscess.
Fifteen liver abscesses occurred in 14 patients (0.2%). Liver abscesses developed in three of 987 (0.3%) TOCE procedures for portal vein obstruction, three of 114 (2.6%) procedures for metastatic tumors, one of 49 (1.8%) for type 1 biliary abnormality, four of 55 (7.4%) for type 2 biliary abnormality, two of 18 (11.1%) for malignant gastrointestinal mucosal lesion, and nine of 2,108 (0.4%) for additional gelatin sponge particle embolization. Univariate and multivariate statistical analysis showed that type 2 biliary abnormality was a significant predisposing factor. The mortality related to liver abscess occurred in two patients (13.3%). Thirteen liver abscesses were successfully treated with parenteral antibiotics and percutaneous catheter drainage. However, irreversible deterioration of liver function occurred in two patients. Two of nine further TOCE procedures in three patients caused recurrent septicemia and liver abscess.
The biliary abnormality prone to ascending biliary infection was the most important predisposing factor to the development of liver abscess after TOCE. Postembolic liver abscess could be effectively managed with percutaneous catheter drainage.
评估经导管油化疗栓塞术(TOCE)后肝肿瘤患者肝脓肿的发生率、诱发因素及临床结局。
在过去6年中,2439例肝肿瘤患者共接受了6255次TOCE手术。通过回顾病历,作者评估了肝脓肿的发生情况、包括门静脉梗阻、转移性肿瘤、胆道异常(1型,单纯胆道梗阻;2型,易发生上行性胆道感染的状态)、恶性胃肠道黏膜病变以及额外的明胶海绵颗粒栓塞等潜在诱发因素在肝脓肿形成中的统计学意义,以及脓肿的临床结局。
14例患者发生了15例肝脓肿(0.2%)。在987例门静脉梗阻的TOCE手术中有3例(0.3%)发生肝脓肿,114例转移性肿瘤手术中有3例(2.6%),49例1型胆道异常手术中有1例(1.8%),55例2型胆道异常手术中有4例(7.4%),18例恶性胃肠道黏膜病变手术中有2例(11.1%),2108例额外明胶海绵颗粒栓塞手术中有9例(0.4%)。单因素和多因素统计分析表明,2型胆道异常是一个重要的诱发因素。与肝脓肿相关的死亡率为2例(13.3%)。13例肝脓肿通过静脉使用抗生素和经皮导管引流成功治疗。然而,2例患者出现了不可逆的肝功能恶化。3例患者中的9次进一步TOCE手术中有2次导致复发性败血症和肝脓肿。
易发生上行性胆道感染的胆道异常是TOCE后肝脓肿发生的最重要诱发因素。栓塞后肝脓肿可通过经皮导管引流有效治疗。